Higher circulating OPG was not significantly associated with a higher risk of breast cancer-specific death but was associated with a higher risk of recurrence among cases diagnosed with ER-PR- disease (HRlog2: 2.18 (95% CI: 1.39–3.40); phet = 0.01). The gene discussed is TNFRSF11B; the disease is breast carcinoma.